Peter Thompson, Chairman and Co-Founder
Professional Overview
Peter Thompson is a seasoned biopharmaceutical executive and investor with over 35 years of experience in the industry. He currently serves as the Chairman and Co-Founder of Terremoto Biosciences, a biotechnology company focused on developing novel therapeutics. As a General Partner at OrbiMed Advisors, he leverages his deep industry expertise to guide investment strategies and identify promising drug development opportunities.
Experience Summary
Current Roles
- Chairman, Co-Founder at Terremoto Biosciences (2024-08-01 to Present): Provides strategic oversight and leadership as the co-founder and chairman of this biopharmaceutical company.
- General Partner at OrbiMed Advisors (2022-01-01 to Present): Advises on investment decisions and portfolio management as a general partner at this leading healthcare investment firm.
- Co-Founder, Chairman at Silverback Therapeutics (2016-04-01 to Present): Co-founded and serves as the chairman of this biotechnology company dedicated to the development of innovative immunotherapies.
- Chairman, Co-Founder at Edgewise Therapeutics (2017-01-01 to Present): Serves as the chairman and co-founder of this biopharmaceutical company focused on developing therapies for rare and debilitating diseases.
- Co-Founder, Director at Corvus Pharmaceuticals (2014-11-01 to Present): Co-founded and serves on the board of directors of this immuno-oncology company.
Career Progression
- CEO, Co-Founder at Terremoto Biosciences (2021-08-01 to 2024-08-01): Served as the CEO and co-founder of this biotechnology company, leading its strategic direction and operations.
- Partner at OrbiMed Advisors (2013-01-01 to 2021-12-01): Held the role of partner at this premier healthcare investment firm, where he was responsible for identifying and evaluating investment opportunities.
- Venture Partner at OrbiMed Advisors (2010-01-01 to 2013-01-01): Served as a venture partner at OrbiMed Advisors, contributing to the firm's investment activities and portfolio management.
- Co-Founder, Chairman, CEO at Silverback Therapeutics (2016-04-01 to 2020-04-01): Founded and led Silverback Therapeutics as the chairman and CEO, guiding the company's development of innovative immunotherapies.
- Venture Partner at ATP Capital (2002-01-01 to 2005-01-01): Held the role of venture partner at this venture capital firm, leveraging his expertise to evaluate and support early-stage biotechnology companies.
- Co-Founder, Chairman, CEO at Trubion Pharmaceuticals (2002-01-01 to 2009-01-01): Co-founded and served as the chairman and CEO of Trubion Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies.
- VP, GM Chiron Informatics at Chiron Corporation (1995-01-01 to 1999-01-01): Held the position of Vice President and General Manager of Chiron Informatics at Chiron Corporation, a prominent biotechnology company.
- VP, R&D at BD (1991-01-01 to 1995-01-01): Served as the Vice President of Research and Development at BD, a leading medical technology company.
- Lab Head at National Cancer Institute (1985-01-01 to 1992-01-01): Began his career as a Lab Head at the National Cancer Institute, where he conducted research and contributed to the understanding of cancer biology.
Academic Background
- Ph.D. in Biochemistry, University of Washington
Areas of Expertise
- Biopharmaceutical industry leadership and management
- Drug discovery and development
- Immunology and oncology
- Strategic investment and portfolio management
- Entrepreneurship and company building
Professional Impact
- Instrumental in the founding and growth of several successful biotechnology and pharmaceutical companies, including Silverback Therapeutics, Edgewise Therapeutics